Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank69
3Y CAGR-38.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-38.6%/yr
Annual compound
Percentile
P69
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202431.59%
202351.71%
2022-62.95%
2021136.24%
20200.00%
20190.00%
2018-100.00%
2017-98.58%
20162928.38%
2015-55.86%